--Canadian private equity fund Brookfield Asset Management has resumed talks with Spanish pharmaceutical company Grifols over a potential takeover bid, five months after dropping out of a first set of negotiations to acquire Grifols, Spain's news website El Confidencial reports, citing unnamed sources.
--The new bid would be for a 7 billion purchase price, El Confidencial writes, citing the same sources.
--Brookfield's general director, Tristan Tully, is holding the talks with the Grifols family through Morgan Stanley, and has requested more detailed information about the producer of plasma-derived medicines, the article says.
--Grifols declined to comment to El Confidencial.
Full story in Spanish: https://tinyurl.com/3f48nxny
Write to Cristina Gallardo at cristina.gallardo@wsj.com
(END) Dow Jones Newswires
April 02, 2025 04:44 ET (08:44 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.